A Randomized, Placebo‐controlled Trial to Assess the Efficacy and Safety of Sitagliptin in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control on Ipragliflozin

A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy

BMC Endocrine Disorders ◽

10.1186/1472-6823-14-17 ◽

2014 ◽

Vol 14 (1) ◽

Cited By ~ 15

Author(s):

Judith L White ◽

Patricia Buchanan ◽

Jia Li ◽

Robert Frederich

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Glycemic Control ◽

Combination Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Metformin Monotherapy ◽

A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control

Diabetes Therapy ◽

10.1007/s13300-017-0270-7 ◽

2017 ◽

Vol 8 (4) ◽

pp. 793-810 ◽

Cited By ~ 2

Author(s):

Ira Gantz ◽

◽

Taro Okamoto ◽

Yuka Ito ◽

Asako Sato ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Safety And Efficacy ◽

Efficacy and Safety of Ipragliflozin in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control on Sitagliptin

Diabetes Obesity and Metabolism ◽

10.1111/dom.14448 ◽

2021 ◽

Author(s):

Kohei Kaku ◽

Takashi Kadowaki ◽

Yutaka Seino ◽

Taro Okamoto ◽

Masayoshi Shirakawa ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Japanese Patients ◽

Efficacy And Safety ◽

Decision letter for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v3/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Review for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v1/review2 ◽

2019 ◽

Author(s):

Bastiaan E de Galan

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12047 ◽

2013 ◽

Vol 15 (5) ◽

pp. 432-440 ◽

Cited By ~ 90

Author(s):

K. Kaku ◽

S. Inoue ◽

O. Matsuoka ◽

A. Kiyosue ◽

H. Azuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(20)30075-9 ◽

2020 ◽

Vol 8 (5) ◽

pp. 377-391 ◽

Cited By ~ 14

Author(s):

Yuichiro Yamada ◽

Hideki Katagiri ◽

Yoshiyuki Hamamoto ◽

Srikanth Deenadayalan ◽

Andrea Navarria ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomised Controlled Trial ◽

Dose Response ◽

Controlled Trial ◽

Japanese Patients ◽

Phase 2 ◽

Efficacy And Safety ◽

Response Efficacy ◽

Randomised Controlled

Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Case Medical Research ◽

10.31525/ct1-nct04170998 ◽

2019 ◽

Author(s):

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Combination Therapy ◽

Efficacy And Safety ◽

Review for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v2/review3 ◽

2019 ◽

Author(s):

Bastiaan E de Galan

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Review for "Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: a randomised, double‐blind, placebo‐controlled trial"

10.1111/dom.13909/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽